The Latest Breaking News from Lifevantage

GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends

GLP-1 weight loss drugs are in short supply enabling lab to make compounded GLP-1 treatments sold for 80% less than the name-brand drugs.

MarketBeat · Feb 12, 2025

Will These 3 Medical Stocks Make Gains in 2024?

Technological advances, rising healthcare costs, and the robust demand for medicines and healthcare services due to an aging population and the rise in chronic diseases are boosting the prospects of the medical sector. So, should you invest in Walgreens Boots Alliance (WBA), Tenet Healthcare (THC) and LifeVantage (LFVN) for gains?…

StockNews.com · Jan 17, 2024

Preview: Lifevantage's Earnings

Lifevantage (NASDAQ:LFVN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Lifevantage will report an earnings per share (EPS) of $0.11.

Benzinga · May 2, 2022